P.A.W. Capital’s Amgen AMGN Stock Holding History

P.A.W. Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,600	Closed	-$811K	–	27
2022 Q3	$811K	Hold	3,600	–	–	1.22%	28
2022 Q2	$876K	Sell	3,600 -400	-10%	-$98K	1.27%	25
2022 Q1	$967K	Hold	4,000	–	–	1.01%	27
2021 Q4	$900K	Buy	+4,000	New	+$844K	0.83%	31
2017 Q4	–	Sell	-8,000	Closed	-$1.49M	–	57
2017 Q3	$1.49M	Sell	8,000 -2,000	-20%	-$354K	1.56%	20
2017 Q2	$1.72M	Hold	10,000	–	–	1.73%	23
2017 Q1	$1.64M	Hold	10,000	–	–	1.66%	25
2016 Q4	$1.46M	Hold	10,000	–	–	1.65%	25
2016 Q3	$1.67M	Buy	10,000 +2,000	+25%	+$338K	1.79%	20
2016 Q2	$1.22M	Buy	8,000 +500	+7%	+$77.7K	1.39%	27
2016 Q1	$1.12M	Buy	7,500 +1,500	+25%	+$223K	1.26%	30
2015 Q4	$974K	Hold	6,000	–	–	1.1%	37
2015 Q3	$830K	Hold	6,000	–	–	0.95%	39
2015 Q2	$921K	Buy	+6,000	New	+$961K	0.93%	39

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

P.A.W. Capital's AMGN Position: Q4 2022 in Review

P.A.W. Capital sold out of Amgen (AMGN) in Q4 2022, closing a stake of 3,600 shares — an estimated $811K sold.

P.A.W. Capital first reported a position in AMGN in Q2 2015 and held it in 14 quarters. The position peaked at $1.72M in Q2 2017. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

P.A.W. Capital reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
P.A.W. Capital sold 3,600 Amgen shares in Q4 2022, an estimated $811K.
P.A.W. Capital first reported a position in Amgen in Q2 2015 and held it in 14 quarters.
P.A.W. Capital's Amgen position peaked at $1.72M in Q2 2017.
2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on P.A.W. Capital's 13F filing for Q4 2022, filed 14 Feb 2023.